Design, Synthesis, and Antitumor Efficacy of Substituted 2-Amino[1,2,4]triazolopyrimidines and Related Heterocycles as Dual Inhibitors for Microtubule Polymerization and Janus Kinase 2
Journal of Medicinal Chemistry · 2023
DOI: 10.1021/acs.jmedchem.3c01690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Li Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Large Animal Models for Biomedicine, School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 52…. Hauptthemen laut MEDLINE: Tubulin, Antineoplastic Agents. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Science and Technology Planning Project of Guangdong Province, National College Students Innovation and Entrepreneurship Training Program, Department of Education of Guangdong Province.
Abstract (Originalsprache)
Preclinical and clinical studies have demonstrated the synergistic effect of microtubule-targeting agents in combination with Janus kinase 2 (JAK2) inhibitors, prompting the development of single agents with enhanced therapeutic efficacy by dually inhibiting tubulin polymerization and JAK2. Herein, we designed and synthesized a series of substituted 2-amino[1,2,4]triazolopyrimidines and related heterocycles as dual inhibitors for tubulin polymerization and JAK2. Most of these compounds exhibited potent antiproliferative activity against the selected cancer cells, with compound 7g being the most active. This compound effectively inhibits both tubulin assembly and JAK2 activity. Furthermore, phosphorylated compound 7g (i.e., compound 7g-P) could efficiently convert to compound 7g in vivo. Compound 7g, whether it was administered directly or in the form of a phosphorylated prodrug (i.e., compound 7g-P), significantly inhibited the growth of A549 xenografts in nude mice. The present findings strongly suggest that compound 7g represents a promising chemotherapeutic agent with high antitumor efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Large Animal Models for Biomedicine, School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, P. R. China.
- Center for Cancer and Inflammation Research, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong 852, P. R. China.
- Department of Pharmacy, Huizhou First Maternal and Child Health Care Hospital, Huizhou 516000, P. R. China.
ORCID-Profile: Jia-Qiang Wu, Zhi-Ling Yu, Wen-Hua Chen, Jinhui Hu
Förderung
- Science and Technology Planning Project of Guangdong Province
- National College Students Innovation and Entrepreneurship Training Program
- Department of Education of Guangdong Province
Zitieren
APA
Chen, L., Hu, Y., Lu, Z., Lin, Z., Li, L., Wu, J. Q., Yu, Z. L., Wang, C., Chen, W. H., & Hu, J. (2023). Design, Synthesis, and Antitumor Efficacy of Substituted 2-Amino[1,2,4]triazolopyrimidines and Related Heterocycles as Dual Inhibitors for Microtubule Polymerization and Janus Kinase 2. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c01690
Vancouver
Chen L, Hu Y, Lu Z, Lin Z, Li L, Wu JQ, et al. Design, Synthesis, and Antitumor Efficacy of Substituted 2-Amino[1,2,4]triazolopyrimidines and Related Heterocycles as Dual Inhibitors for Microtubule Polymerization and Janus Kinase 2. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.3c01690
BibTeX
@article{Chen2023,
author = {Chen, Li and Hu, Yunfei and Lu, Zhonghui and Lin, Zeyin and Li, Lanqing and Wu, Jia-Qiang and Yu, Zhi-Ling and Wang, Chunye and Chen, Wen-Hua and Hu, Jinhui},
title = {Design, Synthesis, and Antitumor Efficacy of Substituted 2-Amino[1,2,4]triazolopyrimidines and Related Heterocycles as Dual Inhibitors for Microtubule Polymerization and Janus Kinase 2},
journal = {Journal of Medicinal Chemistry},
year = {2023},
doi = {10.1021/acs.jmedchem.3c01690}
}
EUVIMED